University of Minnesota CRNA Interview & Requirements (2026)

The University of Minnesota was the first nurse anesthesia program in the United States accredited to offer the entry-level Doctor of Nursing Practice (DNP). Directed by Joanne Donnelly, DNP, APRN, CRNA, the program runs for 36 months (three years, nine semesters) full time, with a new cohort starting each September.

In NursingCAS, the program delivery is listed as Hybrid and On Campus for Nurse Anesthesia, and the Council on Accreditation of Nurse Anesthesia Educational Programs (COA) lists the program as offering distance education. You come to campus one to two days each week for coursework, plus one full week each semester for core courses, enhancement programming, specialty courses, and advisor meetings. The school arranges your clinical placements across urban and rural rotations, where you complete about 3,000 clinical hours. By our calculation from the COA Practice Doctorate Standards (effective January 1, 2026) and UMN's program disclosures, UMN's 3,000 clinical hours are 1,000 hours (50%) above the 2,000-hour national COA minimum.

To practice answering ICU clinical and DNP role questions out loud before your interview day, Confetto runs AI mock interviews for CRNA applicants with follow-up questions on your clinical background. Start your free week.

When you are invited to interview, your invitation email and the admissions team will give you the exact schedule and room or video link for your date. For a broader look at how nurse anesthesia programs structure their interview days across the country, read our guide to CRNA school interviews in 2026-27. At the University of Minnesota, the School of Nursing tells you directly what its admissions committee scores and what clinical skills you must bring from the ICU.

First, expect clinical and pharmacology questions built around UMN's definition of a critical care area. On its Nurse Anesthesia Program Details page, UMN defines a qualifying ICU as one where, on a daily basis, the RN manages four specific areas: invasive hemodynamic monitors (pulmonary artery catheter, CVP, and arterial lines), cardiac assist devices, mechanical ventilation, and vasoactive drips (specifically naming norepinephrine, epinephrine, dobutamine, nicardipine, and nitroglycerine). If you list those drips and devices on your CV, be ready to explain their receptor physiology, titration endpoints, and troubleshooting steps out loud.

Second, expect personal, leadership, and role-readiness questions tied to the School of Nursing's Holistic Application Review criteria. UMN evaluates past academic performance, professional and relevant experience, career reasoning for the specialty, understanding of DNP competencies and career goals, leadership experiences, community involvement, commitment to diversity, equity, and inclusion (DEI), personal attributes (such as self-awareness, grit, and resilience), and writing and communication skills.

• Audit the five named drips. Write down the receptor activity (alpha-1, beta-1, beta-2, or calcium channel blockade), mechanism of action, onset, and primary clinical indication for norepinephrine, epinephrine, dobutamine, nicardipine, and nitroglycerine.
• Review your waveforms and monitors. Practice explaining how to zero and level an arterial line, how to spot an overdamped or underdamped waveform, and what CVP and pulmonary artery catheter numbers tell you about preload, afterload, and contractility.
• Connect your ICU stories to grit and self-awareness. UMN explicitly names self-awareness, grit, and resilience as attributes it looks for. Pick two hard shifts or clinical catches where you recognized your own limit, asked for help early, or adapted under pressure.
• Know your own essays cold. Because UMN prohibits generative AI tools on both the four-page personal statement and the 500-word DEI essay, interviewers expect your spoken answers about DNP leadership and equity to sound just like your written file.
• Prepare a clear explanation of the DNP project. UMN's curriculum includes a three-part DNP Project (Planning, Implementation, and Dissemination) plus courses in Quality Improvement and Healthcare Economics. Have one clinical quality problem from your ICU ready to discuss.

UMN's program details page names five vasoactive infusions as examples of daily critical care management: norepinephrine, epinephrine, dobutamine, nicardipine, and nitroglycerine. You can compare these with our full bank of 38 CRNA school interview questions with answers. Practice these four questions built on UMN's drug list, then study the two worked answers below.

• 1. Compare the receptor profiles of norepinephrine, epinephrine, and dobutamine, and explain how each changes heart rate, contractility, and systemic vascular resistance.
• 2. Both nicardipine and nitroglycerine lower blood pressure. How do their mechanisms of action differ, and when would you reach for one over the other in the ICU?
• 3. Your septic shock patient is on high-dose norepinephrine and the MAP is still 54 mmHg. Walk me through what is happening at the cellular and receptor level, and what you anticipate adding next.
• 4. You start a dobutamine infusion on a cardiogenic shock patient and notice their blood pressure dropping and heart rate climbing to 125 bpm. Why is that happening?

Question: Compare the receptor profiles of norepinephrine and dobutamine, and explain when you would use each in a hypotensive patient.

"In my cardiothoracic ICU, we titrate both of these daily, and the choice comes down to whether the patient has a vascular tone problem or a pump problem. Norepinephrine is primarily a potent alpha-1 adrenergic agonist with modest beta-1 activity. When it binds to alpha-1 receptors on vascular smooth muscle, it activates the Gq protein pathway, increasing intracellular calcium and causing vasoconstriction. That raises systemic vascular resistance and mean arterial pressure. Its beta-1 activity gives a mild boost to myocardial contractility, though the heart rate often stays neutral or drops slightly from the baroreceptor reflex.

"Dobutamine is mainly a beta-1 agonist with weaker beta-2 and minimal alpha-1 activity. Acting through the Gs protein pathway and cyclic AMP, beta-1 stimulation increases inotropy and chronotropy, while beta-2 stimulation in the vasculature causes mild vasodilation and reduces afterload. I use norepinephrine as first-line in distributive or septic shock when SVR is low. I use dobutamine in cardiogenic shock or low cardiac output states after heart surgery when the patient needs contractility support and afterload reduction, though I watch closely for hypotension or tachyarrhythmias."

Example answer written by our team. The applicant is invented.

Question: Both nicardipine and nitroglycerine lower blood pressure. How do their mechanisms differ, and when do you use each?

"Nicardipine is a dihydropyridine calcium channel blocker. It blocks L-type calcium channels primarily on arterial smooth muscle rather than the myocardium, preventing calcium influx and causing selective arterial vasodilation. That drops systemic vascular resistance and afterload without directly depressing cardiac contractility or conduction, and it also dilates cerebral and coronary arteries. In our unit, we use nicardipine for acute stroke blood pressure goals and severe postoperative hypertension where we need steady arterial control.

"Nitroglycerine is an organic nitrate that is converted to nitric oxide in vascular smooth muscle. Nitric oxide activates guanylate cyclase, increasing cyclic GMP, which dephosphorylates myosin light chains and relaxes the vessel. At lower doses, nitroglycerine predominantly dilates venous capacitance vessels, which decreases venous return, preload, and left ventricular end-diastolic pressure. At higher doses, it also dilates arteries and coronary vessels. I titrate nitroglycerine when a patient has acute cardiogenic pulmonary edema or myocardial ischemia, where unloading preload and improving coronary perfusion is the main goal."

Example answer written by our team. The applicant is invented.

Along with vasoactive drips, UMN requires daily competence with invasive hemodynamic monitors (pulmonary artery catheters, CVP, and arterial lines), cardiac assist devices, and mechanical ventilation. Here are five clinical scenario questions that test those exact skills, followed by a worked example.

• 1. Walk me through how you interpret a pulmonary artery catheter profile to distinguish between hypovolemic, cardiogenic, and septic shock.
• 2. Your patient's arterial line waveform suddenly looks flat with no dicrotic notch, and the cuff pressure is 30 points higher than the arterial line systolic reading. How do you troubleshoot this?
• 3. A mechanically ventilated patient in your ICU suddenly triggers a high peak inspiratory pressure alarm. How do you use plateau pressure to figure out what is wrong?
• 4. If you have cared for patients on a cardiac assist device such as an intra-aortic balloon pump (IABP), explain the timing of inflation and deflation and what each does for the heart.
• 5. A post-op patient on mechanical ventilation has an ABG showing pH 7.24, PaCO2 58, PaO2 88, and HCO3 24. Interpret the gas and explain what ventilator adjustments you would consider.

Question: A mechanically ventilated patient in your ICU suddenly triggers a high peak inspiratory pressure alarm. How do you use plateau pressure to figure out what is wrong?

"First, I look at the patient, check their oxygen saturation, auscultate bilateral breath sounds, and make sure the endotracheal tube hasn't migrated or kinked. If the patient is in severe distress or desaturating, I disconnect them from the ventilator and manually bag them with 100% oxygen to feel the compliance in my hands.

"To narrow down the cause on the ventilator, I perform an inspiratory hold maneuver to measure the plateau pressure. Peak inspiratory pressure reflects both airway resistance and lung compliance, while plateau pressure reflects static alveolar compliance alone because airflow is paused. If the peak inspiratory pressure is high but the plateau pressure is unchanged and stays under 30 cm H2O, the problem is increased airway resistance. I check for secretions needing suctioning, bronchospasm, a patient biting the tube, or water in the circuit. If both the peak inspiratory pressure and the plateau pressure are elevated, the problem is decreased lung or chest wall compliance. I immediately evaluate for a tension pneumothorax, mainstem intubation, pulmonary edema, worsening ARDS, or abdominal distension."

Example answer written by our team. The applicant is invented.

UMN's holistic review weighs your understanding of the DNP role, your leadership potential to drive healthcare system change, your commitment to diversity, equity, and inclusion, and personal attributes like grit and self-awareness. Use these prompts to rehearse the behavioral half of your interview.

• 1. Why the University of Minnesota Nurse Anesthesia program, and how does our hybrid schedule and 3,000-hour urban and rural clinical model fit how you learn?
• 2. UMN was the first program in the country accredited to offer the entry-level DNP in nurse anesthesia. How does a DNP-prepared CRNA contribute differently to a health system than a master's-prepared clinician?
• 3. Tell us about a time in the ICU when you had to show grit or resilience over a long period. What kept you grounded?
• 4. Describe a clinical situation where your own self-awareness kept a patient safe or improved how your team functioned.
• 5. How have you contributed to diversity, equity, and inclusion in your nursing practice, and how will you carry that into anesthesia care across diverse urban and rural populations?
• 6. In your third year here, you will complete DNP Project Planning, Implementation, and Dissemination. What quality improvement or patient safety issue from your ICU has made you curious about system-level change?

The University of Minnesota Nurse Anesthesia Area of Study received the maximum 10-year accreditation approval from the Council on Accreditation of Nurse Anesthesia Educational Programs (COA) in November 2019, and its next review is scheduled for fall 2029 (listed as October 2029 on the COA's July 17, 2025 accredited programs report). The broader DNP program is also accredited by the Commission on Collegiate Nursing Education (CCNE).

On its Nurse Anesthesia specialty page, UMN posts six years of first-time National Certification Exam (NCE) pass rates alongside its attrition and employment disclosures. By our calculation from UMN's published disclosures table, the six-year average first-time NCE pass rate from 2021 through 2026 is 95.3% (572 divided by 6). For the Class of 2025 specifically, UMN reports a 93% first-time NCE pass rate and a 100% overall NCE pass rate, with graduates completing 3,000 clinical hours each and achieving an average of 570% above regional accreditation requirements.

When you are ready to test your clinical and behavioral answers under realistic pressure, use Confetto to run timed CRNA mock interviews with instant feedback on your pharmacology explanations and personal stories. Start your free week.

Your post-cardiotomy patient has a blood pressure of 78/46 (MAP 57), CVP of 16 mmHg, pulmonary artery pressure of 48/26 mmHg, PAOP (wedge) of 22 mmHg, cardiac index of 1.7 L/min/m2, and SVR of 1,650 dynes/sec/cm-5. What is your hemodynamic assessment, and which vasoactive infusion from UMN's critical care list would you anticipate starting?

• UMN School of Nursing: Nurse Anesthesia Specialty
• UMN School of Nursing: Nurse Anesthesia Program Details & Critical Care Experience
• UMN School of Nursing: DNP Before You Apply
• UMN School of Nursing: DNP How to Apply
• UMN School of Nursing: DNP Dates and Deadlines
• UMN School of Nursing: DNP Cost and Financial Support
• COA: List of Accredited Educational Programs (July 17, 2025)
• COA: Standards for Accreditation of Nurse Anesthesia Programs - Practice Doctorate (Effective Jan 1, 2026)